High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen

Ndjeka, Norbert; Schnippel, Kathryn; Master, Iqbal; Meintjes, Graeme; Maartens, Gary; Romero, Rodolfo; Padanilam, Xavier; Enwerem, Martin; Chotoo, Sunitha; Singh, Nalini; Hughes, Jennifer; Variava, Ebrahim; Ferreira, Hannetjie; te Riele, Julian; Ismail, Nazir; Mohr-Holland, Erika; Bantubani, Nonkqubela; Conradie, Francesca

doi:10.1183/13993003.01528-2018

Public

High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen

Published in European Respiratory Journal • Oct 25, 2018

Authors:

Norbert Ndjeka

Kathryn Schnippel

Iqbal Master

Abstract

South African patients with rifampicin-resistant tuberculosis (TB) and resistance to fluoroquinolones and/or injectable drugs (extensively drug-resistant (XDR) and preXDR-TB) were granted access to bedaquiline through a clinical access programme with strict inclusion and exclusion criteria. PreXDR-T...

Subject

Bedaquiline

Medicine

Regimen

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!